About Malaysia Palm Oil Board
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Malaysia Palm Oil Board
During the past decade, Malaysia Palm Oil Board conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
2016-10-01
2017-10-18
Completed
317
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
2016-11-07
2019-02-13
Completed
259
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
2017-10-31
2019-08-19
Completed
550
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
2017-10-31
2019-04-17
Completed
567
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Malaysia Palm Oil Board"
#1 collaborator was "University of Malaya" with 4 trials as a collaborator, "Universiti Putra Malaysia" with 3 trials as a collaborator, "International Medical University (IMU), Kuala Lumpur,Malaysia" with 1 trials as a collaborator and "Ministry of Health, Malaysia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Malaysia Palm Oil Board
According to Clinical.Site data, the most researched conditions in "Malaysia Palm Oil Board" are
"Metabolic Syndrome" (3 trials), "Cardiovascular Risk Factor" (2 trials), "Inflammation" (2 trials), "Breast Cancer" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Malaysia Palm Oil Board" in a lesser frequency.
Clinical Trials Intervention Types at Malaysia Palm Oil Board
Most popular intervention types in "Malaysia Palm Oil Board" are "Dietary Supplement" (8 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Acute Effects of Fats and Carbohydrate" (1 trials), "Chemically interesterified palm olein (IV56)" (1 trials), "Gamma delta TRF" (1 trials) and "High oleic sunflower oil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Malaysia Palm Oil Board
The vast majority of trials in "Malaysia Palm Oil Board" are
9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Malaysia Palm Oil Board
Currently, there are NaN active trials in "Malaysia Palm Oil Board".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Malaysia Palm Oil Board,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Malaysia Palm Oil Board, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 11 trials that are defined as “Not Applicable".